Part I: Early Alzheimer Disease Detection with the DAC-SP Blueprint Program: Overview of a Scalable Health System Approach
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- Practice Management
Microplastics and "Negative Neuroplasticity": An Emerging Topic in Clinical Neurology
Keshav Shah, MBBS; David Davis, PhDKeshav Shah, MBBS; David Davis, PhD - Neurology in Motion
How to Communicate the Results of Alzheimer Disease Biomarker Tests with Patients
Suzanne E. Schindler, MD, PhDSuzanne E. Schindler, MD, PhD - Movement Disorders
Diagnosis and Management of Dementia and Psychosis in Individuals With Parkinson Disease
Jorge Patino, MD; Abhimanyu Mahajan, MD, MHSJorge Patino, MD; Abhimanyu Mahajan, MD, MHS
